The high sensitivity and specificity indicate SleepCheck can potential be classified as a diagnostic tool (unlike Drowzle which is the only competitor with similar technology but has very low specificity of 63% and can only detect AHI>=15) which management indicate they are planning later but right now best to get the product out to the population and earn some revenue.
Ann: Continued Use of ResAppDx at COVID-19 Respiratory Clinic, page-140
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)